Integra Therapeutics — Other · €10.5M

Integra Therapeutics, a Pompeu Fabra University spin-off developing the FiCAT gene-writing platform, was awarded up to €10.5 million by the European Commission through the EIC Accelerator, structured as a €2.5 million grant plus up to €8 million of equity from the EIC Fund. It was one of only 68 deeptech companies selected out of 969 applicants.